APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coartem (Artemether & Lumefantrine)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Coartem (Artemether & Lumefantrine) Industry Growth and Trends Forecast to 2032

20 December 202597 pages

Choose your research edition.

Industry ResearchCoartem (Artemether & Lumefantrine) Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Coartem (Artemether & Lumefantrine) Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Coartem (Artemether & Lumefantrine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coartem (Artemether & Lumefantrine) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Coartem (Artemether & Lumefantrine) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Coartem (Artemether & Lumefantrine) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Coartem (Artemether & Lumefantrine) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Coartem (Artemether & Lumefantrine) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coartem (Artemether & Lumefantrine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Coartem (Artemether & Lumefantrine) include Novartis, Kunming Pharmaceutical, Kerui Nanhai Pharmaceutical, Guilin Pharmaceutical Co., Ltd, Guangxi Xiancaotang Pharmaceutical Co., LTD, Sanofi-Aventis and KPC Pharmaceuticals, Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Coartem (Artemether & Lumefantrine) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Coartem (Artemether & Lumefantrine) market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Coartem (Artemether & Lumefantrine) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Coartem (Artemether & Lumefantrine).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Coartem (Artemether & Lumefantrine) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Coartem (Artemether & Lumefantrine) Market by Company

Novartis

Kunming Pharmaceutical

Kerui Nanhai Pharmaceutical

Guilin Pharmaceutical Co., Ltd

Guangxi Xiancaotang Pharmaceutical Co., LTD

Sanofi-Aventis

KPC Pharmaceuticals, Inc

Coartem (Artemether & Lumefantrine) Segment by Type

Artemether

Lumefantrine

Coartem (Artemether & Lumefantrine) Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Coartem (Artemether & Lumefantrine) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coartem (Artemether & Lumefantrine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coartem (Artemether & Lumefantrine) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coartem (Artemether & Lumefantrine).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Coartem (Artemether & Lumefantrine) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Coartem (Artemether & Lumefantrine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Artemether Table 2. Major Company of Lumefantrine Table 3. Global Coartem (Artemether & Lumefantrine) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (k units) Table 5. Global Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Type (2021-2026) Table 8. Global Coartem (Artemether & Lumefantrine) Price by Type (2021-2026) & (US$/unit) Table 9. Global Coartem (Artemether & Lumefantrine) Sales by Type (2027-2032) & (k units) Table 10. Global Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Coartem (Artemether & Lumefantrine) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Type (2027-2032) Table 13. Global Coartem (Artemether & Lumefantrine) Price by Type (2027-2032) & (US$/unit) Table 14. North America Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (k units) Table 15. North America Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (k units) Table 17. Europe Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (k units) Table 21. Latin America Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (US$ Million) Table 24. Coartem (Artemether & Lumefantrine) Industry Trends Table 25. Coartem (Artemether & Lumefantrine) Industry Drivers Table 26. Coartem (Artemether & Lumefantrine) Industry Opportunities and Challenges Table 27. Coartem (Artemether & Lumefantrine) Industry Restraints Table 28. Global Coartem (Artemether & Lumefantrine) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Company (2021-2026) Table 30. Global Coartem (Artemether & Lumefantrine) Sales by Company (2021-2026) & (k units) Table 31. Global Coartem (Artemether & Lumefantrine) Sales Share by Company (2021-2026) Table 32. Global Coartem (Artemether & Lumefantrine) Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Coartem (Artemether & Lumefantrine) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Coartem (Artemether & Lumefantrine) Major Company Production Sites and Headquarters Table 35. Global Coartem (Artemether & Lumefantrine) Company, Product Type & Application Table 36. Global Coartem (Artemether & Lumefantrine) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Coartem (Artemether & Lumefantrine) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Coartem (Artemether & Lumefantrine) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Coartem (Artemether & Lumefantrine) Sales by Region (2021-2026) & (k units) Table 41. Global Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Coartem (Artemether & Lumefantrine) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Region (2021-2026) Table 44. Global Coartem (Artemether & Lumefantrine) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Coartem (Artemether & Lumefantrine) Sales by Region (2027-2032) & (k units) Table 46. Global Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Coartem (Artemether & Lumefantrine) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Region (2027-2032) Table 49. Global Coartem (Artemether & Lumefantrine) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Coartem (Artemether & Lumefantrine) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (k units) Table 52. Global Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Application (2021-2026) Table 55. Global Coartem (Artemether & Lumefantrine) Price by Application (2021-2026) & (US$/unit) Table 56. Global Coartem (Artemether & Lumefantrine) Sales by Application (2027-2032) & (k units) Table 57. Global Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Coartem (Artemether & Lumefantrine) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Application (2027-2032) Table 60. Global Coartem (Artemether & Lumefantrine) Price by Application (2027-2032) & (US$/unit) Table 61. North America Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (k units) Table 62. North America Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (k units) Table 64. Europe Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (k units) Table 68. Latin America Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Coartem (Artemether & Lumefantrine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Novartis Coartem (Artemether & Lumefantrine) Product Portfolio Table 75. Novartis Recent Development Table 76. Kunming Pharmaceutical Company Information Table 77. Kunming Pharmaceutical Business Overview Table 78. Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio Table 80. Kunming Pharmaceutical Recent Development Table 81. Kerui Nanhai Pharmaceutical Company Information Table 82. Kerui Nanhai Pharmaceutical Business Overview Table 83. Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio Table 85. Kerui Nanhai Pharmaceutical Recent Development Table 86. Guilin Pharmaceutical Co., Ltd Company Information Table 87. Guilin Pharmaceutical Co., Ltd Business Overview Table 88. Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Product Portfolio Table 90. Guilin Pharmaceutical Co., Ltd Recent Development Table 91. Guangxi Xiancaotang Pharmaceutical Co., LTD Company Information Table 92. Guangxi Xiancaotang Pharmaceutical Co., LTD Business Overview Table 93. Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Product Portfolio Table 95. Guangxi Xiancaotang Pharmaceutical Co., LTD Recent Development Table 96. Sanofi-Aventis Company Information Table 97. Sanofi-Aventis Business Overview Table 98. Sanofi-Aventis Coartem (Artemether & Lumefantrine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Sanofi-Aventis Coartem (Artemether & Lumefantrine) Product Portfolio Table 100. Sanofi-Aventis Recent Development Table 101. KPC Pharmaceuticals, Inc Company Information Table 102. KPC Pharmaceuticals, Inc Business Overview Table 103. KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Product Portfolio Table 105. KPC Pharmaceuticals, Inc Recent Development Table 106. North America Coartem (Artemether & Lumefantrine) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. North America Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026) & (k units) Table 108. North America Coartem (Artemether & Lumefantrine) Sales Market Share by Country (2021-2026) Table 109. North America Coartem (Artemether & Lumefantrine) Sales Forecast by Country (2027-2032) & (k units) Table 110. North America Coartem (Artemether & Lumefantrine) Sales Market Share Forecast by Country (2027-2032) Table 111. North America Coartem (Artemether & Lumefantrine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Coartem (Artemether & Lumefantrine) Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Coartem (Artemether & Lumefantrine) Market Share by Country (2021-2026) Table 114. North America Coartem (Artemether & Lumefantrine) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Coartem (Artemether & Lumefantrine) Market Share Forecast by Country (2027-2032) Table 116. Europe Coartem (Artemether & Lumefantrine) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Europe Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026) & (k units) Table 118. Europe Coartem (Artemether & Lumefantrine) Sales Market Share by Country (2021-2026) Table 119. Europe Coartem (Artemether & Lumefantrine) Sales Forecast by Country (2027-2032) & (k units) Table 120. Europe Coartem (Artemether & Lumefantrine) Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Coartem (Artemether & Lumefantrine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Coartem (Artemether & Lumefantrine) Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Coartem (Artemether & Lumefantrine) Market Share by Country (2021-2026) Table 124. Europe Coartem (Artemether & Lumefantrine) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Coartem (Artemether & Lumefantrine) Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Coartem (Artemether & Lumefantrine) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026) & (k units) Table 128. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Forecast by Country (2027-2032) & (k units) Table 130. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Coartem (Artemether & Lumefantrine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Coartem (Artemether & Lumefantrine) Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Coartem (Artemether & Lumefantrine) Market Share by Country (2021-2026) Table 134. Asia-Pacific Coartem (Artemether & Lumefantrine) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Coartem (Artemether & Lumefantrine) Market Share Forecast by Country (2027-2032) Table 136. Latin America Coartem (Artemether & Lumefantrine) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Latin America Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026) & (k units) Table 138. Latin America Coartem (Artemether & Lumefantrine) Sales Market Share by Country (2021-2026) Table 139. Latin America Coartem (Artemether & Lumefantrine) Sales Forecast by Country (2027-2032) & (k units) Table 140. Latin America Coartem (Artemether & Lumefantrine) Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Coartem (Artemether & Lumefantrine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Coartem (Artemether & Lumefantrine) Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Coartem (Artemether & Lumefantrine) Market Share by Country (2021-2026) Table 144. Latin America Coartem (Artemether & Lumefantrine) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Coartem (Artemether & Lumefantrine) Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Coartem (Artemether & Lumefantrine) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026) & (k units) Table 148. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Forecast by Country (2027-2032) & (k units) Table 150. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Coartem (Artemether & Lumefantrine) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Coartem (Artemether & Lumefantrine) Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Coartem (Artemether & Lumefantrine) Market Share by Country (2021-2026) Table 154. Middle East and Africa Coartem (Artemether & Lumefantrine) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Coartem (Artemether & Lumefantrine) Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Coartem (Artemether & Lumefantrine) Distributors List Table 159. Coartem (Artemether & Lumefantrine) Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Coartem (Artemether & Lumefantrine) Image Figure 2. Global Coartem (Artemether & Lumefantrine) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coartem (Artemether & Lumefantrine) Market Size (2021-2032) & (US$ Million) Figure 4. Global Coartem (Artemether & Lumefantrine) Sales (2021-2032) & (k units) Figure 5. Artemether Image Figure 6. Global Artemether Sales YoY Growth (2021-2032) & (k units) Figure 7. Lumefantrine Image Figure 8. Global Lumefantrine Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Coartem (Artemether & Lumefantrine) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Coartem (Artemether & Lumefantrine) Market Share by Type 2025 VS 2032 Figure 11. North America Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Type in 2025 Figure 12. North America Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Type in 2025 Figure 13. Europe Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Coartem (Artemether & Lumefantrine) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Retail Pharmacy Image Figure 24. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 25. Online Pharmacy Image Figure 26. Global Online Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 27. Hospital Pharmacy Image Figure 28. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Coartem (Artemether & Lumefantrine) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Coartem (Artemether & Lumefantrine) Market Share by Application 2025 VS 2032 Figure 31. North America Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Application in 2025 Figure 32. North America Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Application in 2025 Figure 33. Europe Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Application in 2025 Figure 34. Europe Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Application in 2025 Figure 37. Latin America Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Market Share in Value by Application in 2025 Figure 41. North America Coartem (Artemether & Lumefantrine) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Coartem (Artemether & Lumefantrine) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Coartem (Artemether & Lumefantrine) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Coartem (Artemether & Lumefantrine) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Coartem (Artemether & Lumefantrine) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Coartem (Artemether & Lumefantrine) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Coartem (Artemether & Lumefantrine) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Coartem (Artemether & Lumefantrine) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Coartem (Artemether & Lumefantrine) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Coartem (Artemether & Lumefantrine) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Coartem (Artemether & Lumefantrine) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Coartem (Artemether & Lumefantrine) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Coartem (Artemether & Lumefantrine) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Coartem (Artemether & Lumefantrine) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Coartem (Artemether & Lumefantrine) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Coartem (Artemether & Lumefantrine) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Coartem (Artemether & Lumefantrine) Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Coartem (Artemether & Lumefantrine) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Artemether
  • Lumefantrine
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Novartis
  • Kunming Pharmaceutical
  • Kerui Nanhai Pharmaceutical
  • Guilin Pharmaceutical Co., Ltd
  • Guangxi Xiancaotang Pharmaceutical Co., LTD
  • Sanofi-Aventis
  • KPC Pharmaceuticals, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Coartem (Artemether & Lumefantrine) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Coartem (Artemether & Lumefantrine) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Coartem (Artemether & Lumefantrine) Market by Type
  6. 1.3.1 Artemether
  7. 1.3.2 Lumefantrine
  8. 1.4 Global Coartem (Artemether & Lumefantrine) Market Size by Type
  9. 1.4.1 Global Coartem (Artemether & Lumefantrine) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Coartem (Artemether & Lumefantrine) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Coartem (Artemether & Lumefantrine) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Coartem (Artemether & Lumefantrine) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Coartem (Artemether & Lumefantrine) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Coartem (Artemether & Lumefantrine) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Coartem (Artemether & Lumefantrine) Industry Trends
  2. 2.2 Coartem (Artemether & Lumefantrine) Industry Drivers
  3. 2.3 Coartem (Artemether & Lumefantrine) Industry Opportunities and Challenges
  4. 2.4 Coartem (Artemether & Lumefantrine) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Coartem (Artemether & Lumefantrine) Revenue (2021-2026)
  2. 3.2 Global Top Players by Coartem (Artemether & Lumefantrine) Sales (2021-2026)
  3. 3.3 Global Top Players by Coartem (Artemether & Lumefantrine) Price (2021-2026)
  4. 3.4 Global Coartem (Artemether & Lumefantrine) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Coartem (Artemether & Lumefantrine) Major Company Production Sites & Headquarters
  6. 3.6 Global Coartem (Artemether & Lumefantrine) Company, Product Type & Application
  7. 3.7 Global Coartem (Artemether & Lumefantrine) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Coartem (Artemether & Lumefantrine) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Coartem (Artemether & Lumefantrine) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Coartem (Artemether & Lumefantrine) Tier 1, Tier 2, and Tier 3
4 Coartem (Artemether & Lumefantrine) Regional Status and Outlook
  1. 4.1 Global Coartem (Artemether & Lumefantrine) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Coartem (Artemether & Lumefantrine) Historic Market Size by Region
  3. 4.2.1 Global Coartem (Artemether & Lumefantrine) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Coartem (Artemether & Lumefantrine) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Coartem (Artemether & Lumefantrine) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Coartem (Artemether & Lumefantrine) Forecasted Market Size by Region
  7. 4.3.1 Global Coartem (Artemether & Lumefantrine) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Coartem (Artemether & Lumefantrine) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Coartem (Artemether & Lumefantrine) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Coartem (Artemether & Lumefantrine) by Application
  1. 5.1 Coartem (Artemether & Lumefantrine) Market by Application
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.2 Global Coartem (Artemether & Lumefantrine) Market Size by Application
  6. 5.2.1 Global Coartem (Artemether & Lumefantrine) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Coartem (Artemether & Lumefantrine) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Coartem (Artemether & Lumefantrine) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Coartem (Artemether & Lumefantrine) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Coartem (Artemether & Lumefantrine) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Coartem (Artemether & Lumefantrine) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Coartem (Artemether & Lumefantrine) Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Kunming Pharmaceutical
  8. 6.2.1 Kunming Pharmaceutical Company Information
  9. 6.2.2 Kunming Pharmaceutical Business Overview
  10. 6.2.3 Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio
  12. 6.2.5 Kunming Pharmaceutical Recent Developments
  13. 6.3 Kerui Nanhai Pharmaceutical
  14. 6.3.1 Kerui Nanhai Pharmaceutical Company Information
  15. 6.3.2 Kerui Nanhai Pharmaceutical Business Overview
  16. 6.3.3 Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio
  18. 6.3.5 Kerui Nanhai Pharmaceutical Recent Developments
  19. 6.4 Guilin Pharmaceutical Co., Ltd
  20. 6.4.1 Guilin Pharmaceutical Co., Ltd Company Information
  21. 6.4.2 Guilin Pharmaceutical Co., Ltd Business Overview
  22. 6.4.3 Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Product Portfolio
  24. 6.4.5 Guilin Pharmaceutical Co., Ltd Recent Developments
  25. 6.5 Guangxi Xiancaotang Pharmaceutical Co., LTD
  26. 6.5.1 Guangxi Xiancaotang Pharmaceutical Co., LTD Company Information
  27. 6.5.2 Guangxi Xiancaotang Pharmaceutical Co., LTD Business Overview
  28. 6.5.3 Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Product Portfolio
  30. 6.5.5 Guangxi Xiancaotang Pharmaceutical Co., LTD Recent Developments
  31. 6.6 Sanofi-Aventis
  32. 6.6.1 Sanofi-Aventis Company Information
  33. 6.6.2 Sanofi-Aventis Business Overview
  34. 6.6.3 Sanofi-Aventis Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sanofi-Aventis Coartem (Artemether & Lumefantrine) Product Portfolio
  36. 6.6.5 Sanofi-Aventis Recent Developments
  37. 6.7 KPC Pharmaceuticals, Inc
  38. 6.7.1 KPC Pharmaceuticals, Inc Company Information
  39. 6.7.2 KPC Pharmaceuticals, Inc Business Overview
  40. 6.7.3 KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Product Portfolio
  42. 6.7.5 KPC Pharmaceuticals, Inc Recent Developments
7 North America by Country
  1. 7.1 North America Coartem (Artemether & Lumefantrine) Sales by Country
  2. 7.1.1 North America Coartem (Artemether & Lumefantrine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026)
  4. 7.1.3 North America Coartem (Artemether & Lumefantrine) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Coartem (Artemether & Lumefantrine) Market Size by Country
  6. 7.2.1 North America Coartem (Artemether & Lumefantrine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Coartem (Artemether & Lumefantrine) Market Size by Country (2021-2026)
  8. 7.2.3 North America Coartem (Artemether & Lumefantrine) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Coartem (Artemether & Lumefantrine) Sales by Country
  2. 8.1.1 Europe Coartem (Artemether & Lumefantrine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026)
  4. 8.1.3 Europe Coartem (Artemether & Lumefantrine) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Coartem (Artemether & Lumefantrine) Market Size by Country
  6. 8.2.1 Europe Coartem (Artemether & Lumefantrine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Coartem (Artemether & Lumefantrine) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Coartem (Artemether & Lumefantrine) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Coartem (Artemether & Lumefantrine) Sales by Country
  2. 9.1.1 Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Coartem (Artemether & Lumefantrine) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Coartem (Artemether & Lumefantrine) Market Size by Country
  6. 9.2.1 Asia-Pacific Coartem (Artemether & Lumefantrine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Coartem (Artemether & Lumefantrine) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Coartem (Artemether & Lumefantrine) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Coartem (Artemether & Lumefantrine) Sales by Country
  2. 10.1.1 South America Coartem (Artemether & Lumefantrine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026)
  4. 10.1.3 South America Coartem (Artemether & Lumefantrine) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Coartem (Artemether & Lumefantrine) Market Size by Country
  6. 10.2.1 South America Coartem (Artemether & Lumefantrine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Coartem (Artemether & Lumefantrine) Market Size by Country (2021-2026)
  8. 10.2.3 South America Coartem (Artemether & Lumefantrine) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Coartem (Artemether & Lumefantrine) Sales by Country
  2. 11.1.1 Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Coartem (Artemether & Lumefantrine) Market Size by Country
  6. 11.2.1 Middle East and Africa Coartem (Artemether & Lumefantrine) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Coartem (Artemether & Lumefantrine) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Coartem (Artemether & Lumefantrine) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Coartem (Artemether & Lumefantrine) Value Chain Analysis
  2. 12.1.1 Coartem (Artemether & Lumefantrine) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Coartem (Artemether & Lumefantrine) Production Mode & Process
  7. 12.2 Coartem (Artemether & Lumefantrine) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Coartem (Artemether & Lumefantrine) Distributors
  10. 12.2.3 Coartem (Artemether & Lumefantrine) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst